申请人:——
公开号:US20040002485A1
公开(公告)日:2004-01-01
A compound of the formula (I):
1
wherein X is hydroxy, protected hydroxy or optionally substituted amino; Y is —COOR
A
wherein R
A
is hydrogen or ester residue, —CONR
B
R
C
wherein R
B
and R
C
each is independently hydrogen or amide residue, optionally substituted aryl or optionally substituted heteroaryl; and A
1
is optionally substituted heteroaryl; provided that a compound wherein Y and/or A
1
is optionally substituted indol-3-yl is excluded, a tautomer, a prodrug, a pharmaceutically acceptable salt or a hydrate thereof has an inhibitory activity against an integrase.
式(I)的化合物:其中X为羟基,保护羟基或可选取代的氨基;Y为—COORA,其中RA为氢或酯基残基,—CONRBRC,其中RB和RC各自独立地为氢或酰胺基残基,可选取代的芳基或可选取代的杂芳基;且A1为可选取代的杂芳基;但其中Y和/或A1为可选取代的吲哚-3-基的化合物被排除,其互变异构体、前药、药物可接受的盐或水合物具有对整合酶的抑制活性。